首页> 外国专利> NEW ANTI-ASTHMATIC DRUG (ASMAKURE) FROM INDIGENOUS HERBS TO CURE THE DISEASE ASTHMA

NEW ANTI-ASTHMATIC DRUG (ASMAKURE) FROM INDIGENOUS HERBS TO CURE THE DISEASE ASTHMA

机译:来自土著草药的新型抗哮喘药(抗药性),可治愈疾病性哮喘

摘要

Asthma is defined as a chronic inflammatory disorder of the airways of the respiratory organ. It is characterized by reversible airflow obstruction causing cough, wheeze, chest lightness and shortness of breath. The inflammation of bronchial wall together with increased eosinophilis and other inflammatory products of the mast cells and lymphocytes further induce the hyper responsiveness of the bronchi so that it in turn, narrows more rapidly in response to a wide range of stimuli. Asmakure the anti-asthma drug has properties with proven pharmacological use for alleviating common cold and persistent cough and finally building up of immunity against recurrence of Asthma. One of the ingredients Adhatoda Vasica Nees (Basak) has a definite expectorant action. In acute bronchitis, it is found to afford immediate relief especially when the sputum is thick and tenacious. The depression of the Vagal terminals further relieves irritation and spasm of the bronchioles.
机译:哮喘被定义为呼吸器官气道的慢性炎性疾病。它的特征是可逆的气流阻塞导致咳嗽,喘息,胸部轻度和呼吸急促。支气管壁发炎以及嗜酸性粒细胞增多和肥大细胞和淋巴细胞的其他发炎产物一起进一步诱发了支气管的高反应性,因此反过来,它响应各种刺激而更快地变窄。 Asmakure抗哮喘药具有经证实的药理作用,可缓解感冒和持续咳嗽,并最终增强抵抗哮喘复发的免疫力。 Adhatoda Vasica Nees(Basak)的成分之一具有明显的祛痰作用。在急性支气管炎中,发现它可以立即缓解症状,尤其是当痰液浓稠而顽强时。迷走神经末梢的凹陷进一步减轻了细支气管的刺激和痉挛。

著录项

  • 公开/公告号WO03043627A8

    专利类型

  • 公开/公告日2006-08-24

    原文格式PDF

  • 申请/专利权人 CHATTERJEE TAPAN KUMAR;

    申请/专利号WO2001IN00203

  • 发明设计人 CHATTERJEE TAPAN KUMAR;

    申请日2001-11-19

  • 分类号A61K9/22;A61K31/216;A61K36/13;A61K36/19;A61K36/54;A61K36/67;A61K36/9064;A61K36/9068;A61P11/06;

  • 国家 WO

  • 入库时间 2022-08-21 21:34:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号